Quantum Biopharma (QNTM) Divestments (2019 - 2024)
Quantum Biopharma recorded quarterly Divestments of $2.7 million in Q4 2024, up 179.32% quarter-over-quarter from -$3.5 million in Q3 2024, and up 919.15% year-over-year from $269579.0 in Q1 2024.
Quantum Biopharma's Divestments history runs 6 years deep, the most recent figure standing at $2.7 million for Q4 2024.
- In Q4 2024, Divestments rose 919.15% year-over-year to $2.7 million; the TTM figure through Dec 2024 stood at -$0.0 (up 100.0% YoY), while the FY2022 annual figure was $12.7 million, changed N/A from the prior year.
- Divestments came in at $2.7 million for Q4 2024 at Quantum Biopharma, up from -$3.5 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $4.3 million in Q1 2020 to a low of -$3.5 million in Q3 2024.
- A 5-year average of $482301.7 and a median of $205488.4 in 2023 frame the typical range for Divestments.
- Across the five-year window, Divestments surged 1297.81% in 2020 and slumped 1184.78% in 2024, its largest moves.
- Quantum Biopharma's Divestments stood at $141397.8 in 2020, then plunged by 807.22% to -$1.0 million in 2021, then surged by 89.34% to -$106586.0 in 2022, then surged by 352.92% to $269579.0 in 2023, then soared by 919.15% to $2.7 million in 2024.
- According to Business Quant data, Divestments over the past three periods registered $2.7 million, -$3.5 million, and $738222.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | 738,222.00 |
| Mar 31, 2024 | -22,140.00 |
| Dec 31, 2023 | 269,579.00 |
| Sep 30, 2023 | -269,579.00 |
| Mar 31, 2022 | -106,586.00 |
| Jun 30, 2021 | -1.00 Mn |
| Mar 31, 2021 | 500,000.00 |
| Sep 30, 2020 | 141,397.83 |
| Jun 30, 2020 | 1.91 Mn |
| Mar 31, 2020 | 4.35 Mn |
| Mar 31, 2019 | -362,758.09 |